fashion -WSS

fashion

author：entertainment 2025-09-27 10:01:11 - browse：4639

A caretaker speaks with an elderly Alzheimer's patient at a nursing home. — ALAIN JOCARD/AFP via Getty Images

For more than 30 years, Alzheimer’s researchers have thought of APOE4 as a major genetic risk factor for most cases of the devastating neurologic disease. But a new study published on Monday argues that this gene variant plays an even more important role than scientists had realized and causes a distinct form of Alzheimer’s.

Researchers analyzed data from more than 13,000 people, including nearly 800 APOE4 homozygotes, people who carry two copies of the gene variant. They found that nearly all of the homozygotes showed biological signs of Alzheimer’s in the brain, and they typically developed dementia and other symptoms, and died sooner, than people with Alzheimer’s who lack APOE4.

The research team also found that APOE4 homozygotes showed a predictable pattern of biomarker changes linked to Alzheimer’s, including a buildup of beta-amyloid and tau, a protein linked to neuron damage and death.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Obamacare plans could cover weight loss drugs

focus

WSS

Ukraine seeks to reclaim its role as a hub for clinical trials

Biden launches a new push to limit health care costs

Petition to FDA: Get the lead out of consumer hair dyes

What to know about OceanGate, the company behind the missing Titanic submersible

NIH fellows want a pay raise. Will that mean less money for grants?

Study: Pain burden is higher in Black NFL players than white ones

Wikipedia

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

WATCH: Why do our ears pop?

Medicare details structure of new drug price negotiation program

Leqembi, other new Alzheimer’s drugs require better biomarkers

Medicare proposal to cover medical devices draws a mixed reaction

FDA warns medical device makers about rise in fabricated data

Continuity nursing helped my family in our darkest PICU moments

Elevance, SCAN deals highlight health insurer acquisition scrutiny

As demand for Covid shots wanes, Moderna seeks its next success

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

hotspot

Bulgari apologizes to China for listing Taiwan as a country after online backlash

New research casts further doubt on a common procedure used with IVF

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Secretariat’s lessons for human medicine

Leqembi, other new Alzheimer’s drugs require better biomarkers

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

leisure time

knowledge

focus

entertainment